Travere Therapeutics CFO Executes Stock Sales Amid Performance Milestone Vesting
Christopher R. Cline, the Chief Financial Officer of Travere Therapeutics, Inc. (NASDAQ:TVTX), has completed two separate transactions involving the sale of company common stock. The total value of the shares sold amounted to $115,368, with transaction prices ranging between $43.95 and $46.65 per share. These sales follow a period where the executi…